Yoshikatsu Kanai
Inventor
Stats
- 22 US patents issued
- 32 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 22 US Patents Issued
- 32 US Applications Filed
- 77 Total Citation Count
- Aug 8, 2022 Most Recent Filing
- Sep 18, 1995 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| Fuji Bio Medix Co., Ltd. | 1
| 2005
|
| JAPAN SCIENCE AND TECHNOLOGY AGENCY | 1
8 | 1999
2004 |
| KIRIN PHARMA KABUSHIKI KAISHA | 2
1 | 2007
2011 |
| ENDOU, HITOSHI | 2
| 2003
|
| THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 1
| 1995
|
| HUMAN CELL SYSTEMS, INC. | 2
5 2 2 | 2002
2004 2006 2007 |
| KNC LABORATORIES CO., LTD. | 2
| 2014
|
| KYOWA HAKKO KIRIN CO., LTD. | 2
1 2 2 | 2007
2011 2013 2015 |
| J-Pharma Co., Ltd. | 1
1 4 1 11 1 1 1 | 1998
1999 2002 2003 2004 2006 2008 2010 |
| NARD INSTITUTE, LTD. | 2
| 2014
|
| OSAKA UNIVERSITY | 4
| 2014
|
| HITOSHI ENDOU | 1
1 | 1998
2003 |
| Fuji Bio Medix Co., Ltd. | 1
| 1998
|
Inventor Addresses
| Address | Duration |
|---|---|
| Dai-machi 1-chome Hachioji-shi, JP | Mar 10, 05 - Mar 10, 05 |
| Hachioji, JP | Jan 17, 06 - Feb 23, 10 |
| Hachioji-shi, JP | Jun 02, 05 - Dec 22, 05 |
| Osaka, JP | Apr 05, 12 - Dec 08, 22 |
| Suita, JP | May 17, 11 - Feb 13, 24 |
| Suita-shi, Osaka, JP | Nov 26, 15 - May 20, 21 |
| Tokyo, JP | Apr 14, 98 - Aug 07, 12 |
| Tokyo-to, JP | Jun 10, 10 - Jun 09, 15 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 11 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 4 |
| C01N: | 1 | |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 11899019 | 2024 | Method for predicting efficacy of anti-PD-1 antibody or anti-PD-L1 antibody therapy, method for evaluating cancer grade, and method for enhancing efficacy of anti-PD-1 antibody or anti-PD-L1 antibody therapy | 0 |
| 2022/0387,636 | 2022 | PHARMACEUTICAL COMPOSITION CONTAINING 211AT-LABELED AMINO ACID DERIVATIVE, AND METHOD FOR PRODUCING SAID PHARMACEUTICAL COMPOSITION | 0 |
| 2021/0148,920 | 2021 | METHOD FOR PREDICTING EFFICACY OF ANTI-PD-1 ANTIBODY OR ANTI-PD-L1 ANTIBODY THERAPY, METHOD FOR EVALUATING CANCER GRADE, AND METHOD FOR ENHANCING EFFICACY OF ANTI-PD-1 ANTIBODY OR ANTI-PD-L1 ANTIBODY THERAPY | 0 |
| 2021/0000,988 | 2021 | PHARMACEUTICAL COMPOSITION CONTAINING 211AT-LABELED AMINO ACID DERIVATIVE, AND METHOD FOR PRODUCING SAID PHARMACEUTICAL COMPOSITION | 0 |
| 9839701 | 2017 | Aromatic amino acid derivative and positron emission topography (PET) probe using the same | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.